Takeda Sues Amneal Over Gout Drug Generic

Law360, New York (October 22, 2013, 4:55 PM EDT) -- Takeda Pharmaceuticals USA Inc. accused generic-drug manufacturer Amneal Pharmaceuticals LLC of infringing its patents for a gout medication in Delaware federal court Monday, adding to Takeda's growing legal battles over the drug.

New Jersey-based Amneal Pharmaceuticals has infringed five of Takeda’s patents for Colcyrs, an oral medication whose active ingredient, colchicine, is designed to reduce the pain of gout attacks and to treat a rare disease known as familial Mediterranean fever, according to the complaint. The action stems from Amneal’s renewed efforts to bring a generic...
To view the full article, register now.